New York, NY -- (SBWIRE) -- 01/23/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: SUPERVALU INC.(NYSE:SVU),Homex Development Corp. (ADR)(NYSE:HXM),Novavax, Inc.(NASDAQ:NVAX),Exelixis, Inc.(NASDAQ:EXEL)
SUPERVALU INC.(NYSE:SVU) reported loss -1.91% and closed at $6.15 with the total traded volume of 4.78M shares. Its market capitalization is $1.60B. The stock has a 52-week high price of 8.76 and its 52-week low was recorded at $3.50.
SUPERVALU INC. (SUPERVALU) is a United States grocery channel. It operates in three segments: Retail food, Save-A-Lot and Independent business.
What SVU Charts Are Signaling for Traders? Find Out Here
Homex Development Corp. (ADR)(NYSE:HXM) gain 49.14% and ended at $1.73.The total traded volume was 4.70M shares and market capitalization arrived at $96.55M. The stock has a 52-week high price of $14.96 and its 52-week low was recorded at $1.08, while during last trade its minimum price was $1.13 and it gained the highest price of $1.75.
Desarrolladora Homex SAB de CV is a Mexico-based homebuilding company. Together with its subsidiaries, the Company is mainly engaged in the promotion, design, development, construction and sale of affordable entry level and middle income residential housing.
Is HXM Buy After The Recent Price Movement? Find Out Here
Novavax, Inc.(NASDAQ:NVAX)’s reported the increase of 0.16% to close at $6.36 with the overall traded volume of 4.58M shares. Its market capitalization on last close reached to $1.33 billion. Its intraday-low price was $6.30 and its hit its day's highest price at $6.49.
Novavax, Inc. (Novavax) is a clinical stage biopharmaceutical company. The Company focuses on developing recombinant vaccines.
Should NVAX a Buy or Sell Now? Find Out Here
Exelixis, Inc.(NASDAQ:EXEL) plunged -2.43% settle at $8.04. Its total traded volume during last trading session was 6.15M shares. The overall market worth of this company is about $1.48B. The 52 week range of the stock remained $4.32 - $8.41, while its day's lowest price was $7.94 and its hit its day's highest price at $8.41.
Exelixis, Inc. (Exelixis) is a biotechnology company engaged in developing small molecule therapies for the treatment of cancer.
What EXEL Charts Are Signaling for Traders? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)